45
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Aging in HIV-Infected Subjects: A New Scenario and a New View

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The prevalence of HIV-infected people aged 50 years or older is increasing rapidly; the proportion will increase from 28% to 73% in 2030. In addition, HIV-infected individuals may be more vulnerable to age-related condition. There is growing evidence that the prevalence of comorbidities and other age-related conditions (geriatric syndromes, functional or neurocognitive/mental problems, polypharmacy, and social difficulties) is higher in the HIV-infected population than in their uninfected counterparts. However, despite the potential impact of this situation on health care, little information exists about the optimal clinical management of older HIV-infected people. Here we examine the age-related conditions in older HIV-infected persons and address clinical management according to author expertise and published literature. Our aim is to advance the debate about the most appropriate management of this population, including less well-studied aspects, such as frequency of screening for psychological/mental and social and functional capabilities.

          Related collections

          Most cited references84

          • Record: found
          • Abstract: not found
          • Article: not found

          Frailty in Older Adults: Evidence for a Phenotype

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

            Human aging is characterized by a chronic, low-grade inflammation, and this phenomenon has been termed as "inflammaging." Inflammaging is a highly significant risk factor for both morbidity and mortality in the elderly people, as most if not all age-related diseases share an inflammatory pathogenesis. Nevertheless, the precise etiology of inflammaging and its potential causal role in contributing to adverse health outcomes remain largely unknown. The identification of pathways that control age-related inflammation across multiple systems is therefore important in order to understand whether treatments that modulate inflammaging may be beneficial in old people. The session on inflammation of the Advances in Gerosciences meeting held at the National Institutes of Health/National Institute on Aging in Bethesda on October 30 and 31, 2013 was aimed at defining these important unanswered questions about inflammaging. This article reports the main outcomes of this session. © The Author 2014. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

              (1993)
                Bookmark

                Author and article information

                Contributors
                Journal
                Biomed Res Int
                Biomed Res Int
                BMRI
                BioMed Research International
                Hindawi
                2314-6133
                2314-6141
                2017
                21 December 2017
                : 2017
                : 5897298
                Affiliations
                1Lluita contra la Sida Foundation, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
                2Universitat de Vic-Universidad Central de Catalunya (UVIC-UCC), Vic, Spain
                3Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK
                4Department of Infectious Diseases, Hospital San Pedro-CIBIR, Logroño, Spain
                5AIDS Research Institute-IRSICAIXA, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
                6Department of Medicine, University of Colorado, Aurora, CO, USA
                7Neuropsychology Unit-Brain, Cognition and Behavior: Clinical Research, Consorci Sanitari de Terrassa, Barcelona, Spain
                8Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, Modena, Italy
                9University College Dublin School of Medicine and Medical Science, Dublin, Ireland
                10Geriatric Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Facultad de Medicina, Universidad Complutense, CIBERFES, Madrid, Spain
                Author notes

                Academic Editor: Lucia Lopalco

                Author information
                http://orcid.org/0000-0001-5298-1734
                http://orcid.org/0000-0002-4268-0150
                Article
                10.1155/2017/5897298
                5753008
                29430462
                b356d1d8-f2d0-4bd5-853d-63941e9b842e
                Copyright © 2017 Eugenia Negredo et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 28 September 2017
                : 16 November 2017
                Categories
                Review Article

                Comments

                Comment on this article